The syndrome of “dry eye” as an outcome adenoviral keratoconjunctivit and its modern treatment

Abstract

Objective. To determine the severity and treatment of the syndrome of "dry eye" patients after adenoviral keratoconjunctivitis. Methods. In 21 patients with syndrome of "dry eye" after adenoviral keratoconjunctivitis were treated tear replacing (kationorm, hiloparin-dresser) and tear incentiving therapy (Restasis). Results. Syndrome of "dry eye" severe and moderate after adenoviral keratoconjunctivitis occurs in 76.2 % of patients of the main group. Appointment therapy syndrome of "dry eye" elevating tear production. Conclusions. Tear replacing (kationorm, hiloparin-comod) are effective in mild to moderate syndrome of "dry eye", while severe syndrome of "dry eye" in addition to the necessary treatment tear replacing and tear incentiving (Restasis).